In Silico Evaluation of an Artificial Pancreas Combining Exogenous Ultrafast-Acting Technosphere Insulin with Zone Model Predictive Control

Компьютерная оценка искусственной поджелудочной железы, сочетающей экзогенный ультрабыстродействующий инсулин Technosphere с зональным модельно-прогнозирующим управлением
Justin J. Lee, Eyal Dassau, Howard Zisser, Rebecca A. Harvey, Lois G. Jovanovic, Francis J. Doyle
2013-01-01

Artificial pancreasIn silico metabolic simulatorPostprandial hyperglycemiaTechnosphere InsulinZone model predictive control
BACKGROUND: Because of the slow pharmacokinetics of subcutaneous (SC) insulin, avoiding postprandial hyperglycemia has been a major challenge for an artificial pancreas (AP) using SC insulin without a meal announcement. METHODS: A semiautomated AP with Technosphere® Insulin (TI; MannKind Corporation, Valencia, CA) was designed to combine pulmonary and SC insulin. Manual inhalation of 10 U ultrafast-absorbing TI at mealtime delivers the first, or cephalic, phase of insulin, and an SC insulin pump controlled by zone model predictive controller delivers second-phase and basal insulin. This AP design was evaluated on 100 in silico subjects from the University of Virginia/Padova metabolic simulator using a protocol of two 50 g carbohydrate (CHO) meals and two 15 g CHO snacks. RESULTS: Simulation analysis shows that the semiautomated AP with TI provides 32% and 16% more time in the controller target zone (80-140 mg/dl) during the 4 h postprandial period, with 39 and 20 mg/dl lower postprandial blood glucose peak on average than the pure feedback AP and the AP with manual feed-forward SC bolus, respectively. No severe hypoglycemia (<50 mg/dl) was observed in any cases. CONCLUSIONS: The semiautomated AP with TI provides maximum time in the clinically accepted region when compared with pure feedback AP and AP with manual feed-forward SC bolus. Furthermore, the semiautomated AP with TI provides a flexible operation (optional TI inhalation) with minimal user interaction, where the controller design can be tailored to specific user needs and abilities to interact with the device.
1
A semiautomated artificial pancreas combines mealtime inhaled ultrafast Technosphere Insulin with pump-delivered subcutaneous insulin controlled by zone model predictive control.
2
Average postprandial glucose peaks were 39 mg/dl lower than with pure feedback control and 20 mg/dl lower than with manual feed-forward subcutaneous boluses.
3
In 100 in silico subjects, the combined system increased postprandial time in the 80–140 mg/dl target zone by 32% versus pure feedback control and 16% versus manual feed-forward subcutaneous bolus control.
4
No severe hypoglycemia below 50 mg/dl occurred in any simulated case.
5
Optional Technosphere Insulin inhalation enables flexible operation with minimal user interaction and allows controller tailoring to user needs and abilities.

A semiautomated artificial pancreas combining exogenous ultrafast-acting Technosphere Insulin inhalation with a subcutaneous insulin pump

Postprandial glycemic control performance, including time in the target glucose zone, blood-glucose peaks, and hypoglycemia risk, under zone model predictive control

Publication Details
Publication Date
2013-01-01
Journal
Journal of Diabetes Science and Technology
Publisher
SAGE Publishing
ISSN
1932-2968
Cited by
18
Access Type
Author Information
Authors
Justin J. Lee
Eyal Dassau
Howard Zisser
Rebecca A. Harvey
Lois G. Jovanovic
Francis J. Doyle
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%